KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Elanco Animal Health (ELAN) Net Income (2017 - 2025)

Elanco Animal Health's Net Income history spans 9 years, with the latest figure at -$276.0 million for Q4 2025.

  • For Q4 2025, Net Income fell 3350.0% year-over-year to -$276.0 million; the TTM value through Dec 2025 reached -$232.0 million, down 168.64%, while the annual FY2025 figure was -$232.0 million, 168.64% down from the prior year.
  • Net Income for Q4 2025 was -$276.0 million at Elanco Animal Health, down from -$34.0 million in the prior quarter.
  • Across five years, Net Income topped out at $364.0 million in Q3 2024 and bottomed at -$1.1 billion in Q3 2023.
  • The 5-year median for Net Income is -$48.0 million (2022), against an average of -$84.6 million.
  • The largest annual shift saw Net Income soared 179.69% in 2022 before it tumbled 3350.0% in 2025.
  • A 5-year view of Net Income shows it stood at -$103.0 million in 2021, then surged by 55.34% to -$46.0 million in 2022, then tumbled by 206.52% to -$141.0 million in 2023, then surged by 94.33% to -$8.0 million in 2024, then crashed by 3350.0% to -$276.0 million in 2025.
  • Per Business Quant, the three most recent readings for ELAN's Net Income are -$276.0 million (Q4 2025), -$34.0 million (Q3 2025), and $11.0 million (Q2 2025).